Charles River Laboratories (CRL) Tops Q3 EPS by 12c, Updates Guidance

Go back to Charles River Laboratories (CRL) Tops Q3 EPS by 12c, Updates Guidance

Charles River Labs (CRL) PT Lowered to $464 at Jefferies

November 4, 2021 7:57 AM EDT

Jefferies analyst David Windley lowered the price target on Charles River Labs (NYSE: CRL) to $464.00 (from $480.00) while maintaining a Buy rating.

The analyst commented, "We are maintaining our Buy rating on 2 key factors: 1) we think demand is strong enough to support DD... More